NCT02196909

Clinical, Biological and NMR Outcome Measures Study for Hereditary Inclusion Body Myopathy Due to Mutation of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine Kinase Gene (GNE)

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Institut de Myologie, France · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The objective of the study is to identify the best clinical and biological outcome measures for further therapeutics approaches.

Conditions

• HIBM

Interventions

Type	Name	Description
OTHER	motor function and strength assessment
OTHER	NMR assessment
OTHER	24h urine and serum collection

Timeline

• Start date: 2014-07-01
• Primary completion: 2018-05-01
• Completion: 2018-05-01
• First posted: 2014-07-22
• Last updated: 2018-08-08

Locations

1 site across 1 country: France